Market Access/ News/ News/ News/ News/ Oncology/ Sales and Marketing First Rituxan biosimilar Truxima set to make its debut in US Phil Taylor biosimilar, Celltrion, Rituxan, Roche, Teva, truxima, US 0 Comment Biosimilar competition to Roche’s big-selling Rituxan has arrived in the US, with Teva gearing up to launch its Share X First Rituxan biosimilar Truxima set to make its debut in US https://pharmaphorum.com/news/first-rituxan-biosimilar-truxima-set-to-makes-its-debut-in-us/
biosimilar, Celltrion, Rituxan, Roche, Teva, truxima, US
0 Comment
